Forest Ends Phenomix Partnership, But Says Its Many Deals Are Bearing Fruit
In same-day earnings call, the specialty pharma company reported year-end fiscal 2010 sales of $4.2 billion, up 6.9 percent.
In same-day earnings call, the specialty pharma company reported year-end fiscal 2010 sales of $4.2 billion, up 6.9 percent.